Anavex Life Sciences Corp (AVXL)

[anders2211]

it seems few people find it odd that a clinical-stage biotech releases a press release of a trial whose data is "statistically significant" but then doesn't include any data. And then has a conference and still doesn't mention data.

What do I know? I was born a skeptic. You just don't see this very often. Either the release of a pr was premature or Missling is struggling significantly to put a positive spin on non-data.

Otherwise, he would have said something; he would have given some numbers. It's just the way it is. Rarely is it any different in biotech. And one has to ask: why is it different this time?

a late response on my part to your post a few days ago.

So how would that work then? Statistically significant is as being pregnant either you are or you are not. How hard would his statement of statistically significant backfire in the near future, in the upcoming publication? What would Missling gain in buying a few months until the publication reveals he flat out lied? You did not say he lied but it is implied. Why would he put his reputation and career on the line if the PDD data is not statistically significant?